Pten deletion in prostate basal or luminal cells has also been carried out to promote PI3K/AKT signal activation in order to determine the prostate cell lineage responsible for subsequent tumor initiation [26, 32, 35], as previously discussed. The gene discussed is PTEN; the disease is neoplasm.